NSE: ONESOURCE | BSE: 544292

Falling Comet

Download real time

1309.50 -37.30 (-2.77%)

41.75% Fall from 52W High

291.2K NSE+BSE Volume

NSE 02 Mar, 2026 3:31 PM (IST)

15,009.6

Market Cap

High in industry

Beta 1Year

Low volatility

Regulatory Approval

OneSource Specialty gets NSE and BSE nod to merge four subsidiaries into itself See details

OneSource Specialty Pharma Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ONESOURCE, BSE:544292 OneSource Specialty Pharma Ltd.

Search Inside the pdf :

OneSource Specialty Pharma Ltd.

13 Nov 2025

1309.50

-2.77%

GLP-1 story delayed not derailed

Buy: OneSource Specialty Pharma...

ICICI Securities Limited

Delay in generic semaglutide approvals from Canadian regulator may shift the launch timeline by a quarter; however, with a few customers securing the approval in India and approvals in Brazil and Saudi Arabia expected to flow in, OneSource’s management remains confident of the upcoming opportunity, and hence, maintains FY28 guidance for its base business.

OneSource Specialty Pharma Ltd. is trading above its 30 day SMA of 1288.7

RESEARCH REPORTS

Buy SEE REPORTS >

pdf